These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 15582024)
21. Zolpidem and triazolam interact differentially with a delay interval on a digit-enter-and-recall task. Rush CR; Baker RW Hum Psychopharmacol; 2001 Mar; 16(2):147-157. PubMed ID: 12404585 [TBL] [Abstract][Full Text] [Related]
22. Anxiolytic-like effect of group III mGlu receptor antagonist is serotonin-dependent. Stachowicz K; Chojnacka-Wójcik E; Kłak K; Pilc A Neuropharmacology; 2007 Feb; 52(2):306-12. PubMed ID: 17020774 [TBL] [Abstract][Full Text] [Related]
23. Modulation of synaptic GABAA receptor function by zolpidem in substantia nigra pars reticulata. Zhang LL; Chen L; Xue Y; Yung WH Acta Pharmacol Sin; 2008 Feb; 29(2):161-8. PubMed ID: 18215344 [TBL] [Abstract][Full Text] [Related]
24. Administration of corticosterone after the first downshift trial enhances consummatory successive negative contrast. Bentosela M; Ruetti E; Muzio RN; Mustaca AE; Papini MR Behav Neurosci; 2006 Apr; 120(2):371-6. PubMed ID: 16719701 [TBL] [Abstract][Full Text] [Related]
25. Possible anti-oxidant and neuroprotective mechanisms of zolpidem in attenuating typical anti-psychotic-induced orofacial dyskinesia: a biochemical and neurochemical study. Bishnoi M; Chopra K; Kulkarni SK Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1130-8. PubMed ID: 17513028 [TBL] [Abstract][Full Text] [Related]
26. The role of previous exposure in the appetitive and consummatory effects of orexigenic neuropeptides. Benoit SC; Clegg DJ; Woods SC; Seeley RJ Peptides; 2005 May; 26(5):751-7. PubMed ID: 15808905 [TBL] [Abstract][Full Text] [Related]
27. A comparison of the effects of a subtype selective and non-selective benzodiazepine receptor agonist in two CO(2) models of experimental human anxiety. Bailey JE; Papadopoulos A; Seddon K; Nutt DJ J Psychopharmacol; 2009 Mar; 23(2):117-22. PubMed ID: 18562427 [TBL] [Abstract][Full Text] [Related]
28. Allopregnanolone produces hyperphagia by reducing neophobia without altering food palatability. Fudge MA; Kavaliers M; Ossenkopp KP Eur Neuropsychopharmacol; 2006 May; 16(4):272-80. PubMed ID: 16246529 [TBL] [Abstract][Full Text] [Related]
29. Trial-selective effects of U50,488H, a kappa-opioid receptor agonist, on consummatory successive negative contrast. Wood MD; Norris JN; Daniel AM; Papini MR Behav Brain Res; 2008 Nov; 193(1):28-36. PubMed ID: 18514923 [TBL] [Abstract][Full Text] [Related]
30. The antinociceptive effect of zolpidem and zopiclone in mice. Pick CG; Chernes Y; Rigai T; Rice KC; Schreiber S Pharmacol Biochem Behav; 2005 Jul; 81(3):417-23. PubMed ID: 15913749 [TBL] [Abstract][Full Text] [Related]
32. Lesions of the medial prefrontal cortex enhance the early phase of psychogenic fever to unexpected sucrose concentration reductions, promote recovery from negative contrast and enhance spontaneous recovery of sucrose-entrained anticipatory activity. Pecoraro N; de Jong H; Ginsberg AB; Dallman MF Neuroscience; 2008 Jun; 153(4):901-17. PubMed ID: 18455879 [TBL] [Abstract][Full Text] [Related]
33. Orosensory stimulation is sufficient and postingestive negative feedback is not necessary for neuropeptide Y to increase sucrose intake. Torregrossa AM; Davis JD; Smith GP Physiol Behav; 2006 Apr; 87(4):773-80. PubMed ID: 16540131 [TBL] [Abstract][Full Text] [Related]
34. Nicotine place preference in a biased conditioned place preference design. Brielmaier JM; McDonald CG; Smith RF Pharmacol Biochem Behav; 2008 Mar; 89(1):94-100. PubMed ID: 18086490 [TBL] [Abstract][Full Text] [Related]